222 related articles for article (PubMed ID: 24616881)
21. Heterogeneity of Stem Cells in the Ovary.
Bhartiya D; Patel H; Sharma D
Adv Exp Med Biol; 2019; 1169():213-223. PubMed ID: 31487026
[TBL] [Abstract][Full Text] [Related]
22. Loss of ovarian function and the risk of ovarian cancer.
Vanderhyden BC
Cell Tissue Res; 2005 Oct; 322(1):117-24. PubMed ID: 15902502
[TBL] [Abstract][Full Text] [Related]
23. Enhanced Reconstitution of Human Erythropoiesis and Thrombopoiesis in an Immunodeficient Mouse Model with Kit(Wv) Mutations.
Yurino A; Takenaka K; Yamauchi T; Nunomura T; Uehara Y; Jinnouchi F; Miyawaki K; Kikushige Y; Kato K; Miyamoto T; Iwasaki H; Kunisaki Y; Akashi K
Stem Cell Reports; 2016 Sep; 7(3):425-438. PubMed ID: 27499200
[TBL] [Abstract][Full Text] [Related]
24. Induction of a menopausal state alters the growth and histology of ovarian tumors in a mouse model of ovarian cancer.
Laviolette LA; Ethier JF; Senterman MK; Devine PJ; Vanderhyden BC
Menopause; 2011 May; 18(5):549-57. PubMed ID: 21221022
[TBL] [Abstract][Full Text] [Related]
25. Detailed morphology of human ovarian surface epithelium focusing on its metaplastic and neoplastic capability.
Okamura H; Katabuchi H
Ital J Anat Embryol; 2001; 106(2 Suppl 2):263-76. PubMed ID: 11732586
[TBL] [Abstract][Full Text] [Related]
26. The role of reproductive hormones in epithelial ovarian carcinogenesis.
Gharwan H; Bunch KP; Annunziata CM
Endocr Relat Cancer; 2015 Dec; 22(6):R339-63. PubMed ID: 26373571
[TBL] [Abstract][Full Text] [Related]
27. Characteristics of stria vascularis melanocytes of viable dominant spotting (Wv/Wv) mouse mutants.
Cable J; Barkway C; Steel KP
Hear Res; 1992 Dec; 64(1):6-20. PubMed ID: 1490901
[TBL] [Abstract][Full Text] [Related]
28. Human fallopian tube epithelium co-culture with murine ovarian follicles reveals crosstalk in the reproductive cycle.
Zhu J; Xu Y; Rashedi AS; Pavone ME; Kim JJ; Woodruff TK; Burdette JE
Mol Hum Reprod; 2016 Nov; 22(11):756-767. PubMed ID: 27542947
[TBL] [Abstract][Full Text] [Related]
29. Cell Origins of High-Grade Serous Ovarian Cancer.
Kim J; Park EY; Kim O; Schilder JM; Coffey DM; Cho CH; Bast RC
Cancers (Basel); 2018 Nov; 10(11):. PubMed ID: 30424539
[TBL] [Abstract][Full Text] [Related]
30. Activated networking of platelet activating factor receptor and FAK/STAT1 induces malignant potential in BRCA1-mutant at-risk ovarian epithelium.
Zhang L; Wang D; Jiang W; Edwards D; Qiu W; Barroilhet LM; Rho JH; Jin L; Seethappan V; Vitonis A; Wang J; Mok SC; Crum C; Cramer DW; Ye B
Reprod Biol Endocrinol; 2010 Jun; 8():74. PubMed ID: 20576130
[TBL] [Abstract][Full Text] [Related]
31. Acquisition of a second mutation of the Tp53 alleles immediately precedes epithelial morphological transformation in ovarian tumorigenicity.
Cai KQ; Wu H; Klein-Szanto AJ; Xu XX
Gynecol Oncol; 2009 Jul; 114(1):18-25. PubMed ID: 19375154
[TBL] [Abstract][Full Text] [Related]
32. Germ stem cells are active in postnatal mouse ovary under physiological conditions.
Guo K; Li CH; Wang XY; He DJ; Zheng P
Mol Hum Reprod; 2016 May; 22(5):316-28. PubMed ID: 26916381
[TBL] [Abstract][Full Text] [Related]
33. The PARP inhibitor, olaparib, depletes the ovarian reserve in mice: implications for fertility preservation.
Winship AL; Griffiths M; Lliberos Requesens C; Sarma U; Phillips KA; Hutt KJ
Hum Reprod; 2020 Aug; 35(8):1864-1874. PubMed ID: 32604417
[TBL] [Abstract][Full Text] [Related]
34. In Utero Exposure to Benzo[a]pyrene Induces Ovarian Mutations at Doses That Deplete Ovarian Follicles in Mice.
Luderer U; Meier MJ; Lawson GW; Beal MA; Yauk CL; Marchetti F
Environ Mol Mutagen; 2019 Jun; 60(5):410-420. PubMed ID: 30353947
[TBL] [Abstract][Full Text] [Related]
35. Pathogenesis of ovarian cancer: lessons from morphology and molecular biology and their clinical implications.
Kurman RJ; Shih IeM
Int J Gynecol Pathol; 2008 Apr; 27(2):151-60. PubMed ID: 18317228
[TBL] [Abstract][Full Text] [Related]
36. Microscopic benign and invasive malignant neoplasms and a cancer-prone phenotype in prophylactic oophorectomies.
Salazar H; Godwin AK; Daly MB; Laub PB; Hogan WM; Rosenblum N; Boente MP; Lynch HT; Hamilton TC
J Natl Cancer Inst; 1996 Dec; 88(24):1810-20. PubMed ID: 8961970
[TBL] [Abstract][Full Text] [Related]
37. Oogenesis in adult mammals, including humans: a review.
Bukovsky A; Caudle MR; Svetlikova M; Wimalasena J; Ayala ME; Dominguez R
Endocrine; 2005 Apr; 26(3):301-16. PubMed ID: 16034186
[TBL] [Abstract][Full Text] [Related]
38. IS "OVARIAN" CANCER A MISNOMER? EXPLORING OVARIAN CANCER ORIGINS IN THE MOUSE.
Cho KR
Trans Am Clin Climatol Assoc; 2018; 129():40-47. PubMed ID: 30166697
[TBL] [Abstract][Full Text] [Related]
39. Age-dependent morphological alterations of human ovaries from populations with and without BRCA mutations.
Cai KQ; Klein-Szanto A; Karthik D; Edelson M; Daly MB; Ozols RF; Lynch HT; Godwin AK; Xu XX
Gynecol Oncol; 2006 Nov; 103(2):719-28. PubMed ID: 16698071
[TBL] [Abstract][Full Text] [Related]
40. Uterotropic hormones produced by ovaries of Sl/Slt mutant mice before spontaneous development of tubular adenomas.
Terada N; Kuroda H; Matsumoto K; Kitamura Y
Jpn J Cancer Res; 1985 Jul; 76(7):590-5. PubMed ID: 3928555
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
